<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201012049002N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-01-09</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Comparison between in-person and couples counseling in reducing anxiety depression and quality of life of HPV positive women</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of in-person and couples counseling on anxiety, depression and quality of life in HPV-positive women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-01-14</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/53095</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Block Randomization: With the size of blocks 3, 6 and 9, 40 people will be randomly assigned to 3 groups. A member of the research team who is not involved in the selection of samples, will determine the random allocation sequence using a computer program, and opaque envelopes in the package will be numbered in order to allocation concealment, Blinding description: The statistical analyst is blinded to the allocation of study groups. In this way, the statistical analyzer does not know which of the data belongs to the control or experimental group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Anogenital (venereal) warts. Condition 2: Mild cervical dysplasia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: This intervention will run virtually and individually in 6 sessions (30 minutes for each session) as a day in between. Telephone counseling to support women with HPV  to overcome their fears and worries will be conducted and answering their questions (about 4 times) . Six training sessions consist of two parts, each of which will be three sessions: In the first part, an educational intervention based on correcting the myths of the disease will be designed to change misunderstandings and negative perceptions about the disease, eliminate misconceptions and relieve stigma. The second part of the training will be based on lifestyle to strengthen the body immune system and eliminate the virus from the body (nutrition, exercise, sleep hygiene and sexual health). The educational booklet compiled by the researcher is presented to the patients at the end of the second session for study, which is designed based on a review of the texts and using the opinion of experts. Intervention 2: Intervention group 2: This intervention will run virtually and couple in 6 sessions (30 minutes for each session) as a day in between. Telephone counseling to support women with HPV  to overcome their fears and worries will be conducted and answering their questions (about 4 times) . Six training sessions consist of two parts, each of which will be three sessions: In the first part, an educational intervention based on correcting the myths of the disease will be designed to change misunderstandings and negative perceptions about the disease, eliminate misconceptions and relieve stigma. The second part of the training will be based on lifestyle to strengthen the body immune system and eliminate the virus from the body (nutrition, exercise, sleep hygiene and sexual health). The educational booklet compiled by the researcher is presented to the patients at the end of the second session for study, which is designed based on a review of the texts and using the opinion of experts. Intervention 3: Control group: In the control group, no intervention will be performed by the researcher and patients will receive only routine care. After the trial, educational content will be provided to them.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There are no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyedeh Tahereh Mirmolaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nursing and Midwifery School, Mirkhani St., Nosrat St., Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733171</zip>
        <telephone>+98 21 6105 4000</telephone>
        <email>mirmolaei@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Kowsar Qaderi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nursing and Midwifery School, Mirkhani St., Nosrat St., Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>61054000</zip>
        <telephone>+98 21 6105 4000</telephone>
        <email>kqaderi@razi.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Receiving Positive result of HPV test
Being literate
Understanding Persian language
no chronic illness
no known mental illness</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>A63.0</hc_code>
      <hc_code>N87.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Anogenital (venereal) warts</hc_keyword>
      <hc_keyword>Mild cervical dysplasia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: This intervention will run virtually and individually in 6 sessions (30 minutes for each session) as a day in between. Telephone counseling to support women with HPV  to overcome their fears and worries will be conducted and answering their questions (about 4 times) . Six training sessions consist of two parts, each of which will be three sessions: In the first part, an educational intervention based on correcting the myths of the disease will be designed to change misunderstandings and negative perceptions about the disease, eliminate misconceptions and relieve stigma. The second part of the training will be based on lifestyle to strengthen the body immune system and eliminate the virus from the body (nutrition, exercise, sleep hygiene and sexual health). The educational booklet compiled by the researcher is presented to the patients at the end of the second session for study, which is designed based on a review of the texts and using the opinion of experts.</i_keyword>
      <i_keyword>Intervention group 2: This intervention will run virtually and couple in 6 sessions (30 minutes for each session) as a day in between. Telephone counseling to support women with HPV  to overcome their fears and worries will be conducted and answering their questions (about 4 times) . Six training sessions consist of two parts, each of which will be three sessions: In the first part, an educational intervention based on correcting the myths of the disease will be designed to change misunderstandings and negative perceptions about the disease, eliminate misconceptions and relieve stigma. The second part of the training will be based on lifestyle to strengthen the body immune system and eliminate the virus from the body (nutrition, exercise, sleep hygiene and sexual health). The educational booklet compiled by the researcher is presented to the patients at the end of the second session for study, which is designed based on a review of the texts and using the opinion of experts.</i_keyword>
      <i_keyword>Control group: In the control group, no intervention will be performed by the researcher and patients will receive only routine care. After the trial, educational content will be provided to them.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety and Depression. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Hospital Anxiety and Depression Scale (HADS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quality of life. Timepoint: Before and 10 weeks after intervention. Method of measurement: QoL SF-36.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-10-31</approval_date>
        <contact_name>Ethical Commitee of School of Nursing and Midwifery and School of Rehabilitation - National Ethics C</contact_name>
        <contact_address>Nursing and Midwifery School, Mirkhani St., Nosrat St., Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
